Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
NCT03689595
·
clinicaltrials.gov ↗
RECRUITING
Status
30000
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
OTHER:
Sample of Blood
Sponsor
Dana-Farber Cancer Institute